Over the last 2 weeks, the biotech community has been all about collaborations, with partnerships facilitating the evaluation of off-target chemotherapeutic toxicities, the launch of the Trillion Cell Atlas and the advancement of veterinary immunology research. Plus, we gain an insight into what we can expect at the 2026 AACR Annual Meeting (17–22 April; CA, USA) from Ryvu Therapeutics (Kraków, Poland), as well as the lineup for The Society of Laboratory Automation and Screening (SLAS; IL, USA) Innovation AveNEW program at SLAS Europe 2026 Conference and Exhibition (19–21 May; Vienna, Austria). Products Cell barcoding technology for faster drug discovery Biotium (CA, USA), a provider of fluorescent reagents and kits for life science research, has announced the release of the ViaPlex™ 2-Color Cell Barcoding Kit. Combining fluorescent staining with two reactive dyes, the ViaPlex™ kit allows researchers to label and combine up to 15 distinct cell populations for multiplex analysis in a single tube, reducing reagent consumption and sample running time without compromising data quality. Read the full release >>> Accessing accurate affinity predictions to guide compound optimization Optibrium (Cambridge, UK), a developer of software and AI solutions for molecular design, has announced a new QuanSA™ plugin for PyMOL, providing an intuitive graphical user interface for its ligand-based binding affinity prediction method, part of their BioPharmics 3D molecular modeling platform. The new interface facilitates chemists’ access to accurate affinity predictions that guide the design of potent compounds and reduces the synthesis and testing burden in lead optimization. Read the full release…
